Skip to content

Emily M. Leproust, Chief Executive Officer at Twist Bioscience, sold TWST on Oct 1, 2026

Data as of Oct 16

▼ SELL$131K655 shares at $200.00Emily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp
Watch TWST
Traded
Oct 1, 2026
Disclosed
Oct 5, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Emily M. Leproust, Chief Executive Officer at Twist Bioscience, sold TWST on Oct 1, 2026TRADEDDISCLOSED
TWSTSimilar stocks (XLV — its sector index fund), rebased to TWST's price on the disclosure day
TWST since disclosure
−35.2%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Oct 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$8.6Mdisclosed Oct 5 · filed 3 days after the trade

See every trade on TWST →